AMPK Methods and Protocols

(Rick Simeone) #1
Genetic advances in sarcomeric cardiomyopa-
thies: state of the art. Cardiovasc Res 105
(4):397–408. https://doi.org/10.1093/cvr/
cvv025


  1. Laforet P, Richard P, Said MA, Romero NB,
    Lacene E, Leroy JP, Baussan C, Hogrel JY,
    Lavergne T, Wahbi K, Hainque B, Duboc D
    (2006) A new mutation in PRKAG2 gene caus-
    ing hypertrophic cardiomyopathy with con-
    duction system disease and muscular
    glycogenosis. Neuromuscul Disord 16
    (3):178–182. https://doi.org/10.1016/j.
    nmd.2005.12.004. S0960-8966(05)00354-
    8 [pii]

  2. Cheung PC, Salt IP, Davies SP, Hardie DG,
    Carling D (2000) Characterization of
    AMP-activated protein kinase gamma-subunit
    isoforms and their role in AMP binding. Bio-
    chem J 346(Pt 3):659–669

  3. Nagata D, Hirata Y (2010) The role of
    AMP-activated protein kinase in the cardiovas-
    cular system. Hypertens Res 33(1):22–28.
    https://doi.org/10.1038/hr.2009.187

  4. Kottgen A, Pattaro C, Boger CA,
    Fuchsberger C, Olden M, Glazer NL,
    Parsa A, Gao X, Yang Q, Smith AV, O’Connell
    JR, Li M, Schmidt H, Tanaka T, Isaacs A,
    Ketkar S, Hwang SJ, Johnson AD,
    Dehghan A, Teumer A, Pare G, Atkinson EJ,
    Zeller T, Lohman K, Cornelis MC, Probst-
    Hensch NM, Kronenberg F, Tonjes A,
    Hayward C, Aspelund T, Eiriksdottir G, Lau-
    ner LJ, Harris TB, Rampersaud E, Mitchell
    BD, Arking DE, Boerwinkle E, Struchalin M,
    Cavalieri M, Singleton A, Giallauria F,
    Metter J, de Boer IH, Haritunians T,
    Lumley T, Siscovick D, Psaty BM, Zillikens
    MC, Oostra BA, Feitosa M, Province M, de
    Andrade M, Turner ST, Schillert A, Ziegler A,
    Wild PS, Schnabel RB, Wilde S, Munzel TF,
    Leak TS, Illig T, Klopp N, Meisinger C, Wich-
    mann HE, Koenig W, Zgaga L, Zemunik T,
    Kolcic I, Minelli C, FB H, Johansson A, Igl W,
    Zaboli G, Wild SH, Wright AF, Campbell H,
    Ellinghaus D, Schreiber S, Aulchenko YS, Felix
    JF, Rivadeneira F, Uitterlinden AG, Hofman A,
    Imboden M, Nitsch D, Brandstatter A,
    Kollerits B, Kedenko L, Magi R, Stumvoll M,
    Kovacs P, Boban M, Campbell S, Endlich K,
    Volzke H, Kroemer HK, Nauck M, Volker U,
    Polasek O, Vitart V, Badola S, Parker AN, Rid-
    ker PM, Kardia SL, Blankenberg S, Liu Y, Cur-
    han GC, Franke A, Rochat T, Paulweber B,
    Prokopenko I, Wang W, Gudnason V, Shuldi-
    ner AR, Coresh J, Schmidt R, Ferrucci L, Shli-
    pak MG, van Duijn CM, Borecki I, Kramer BK,
    Rudan I, Gyllensten U, Wilson JF, Witteman
    JC, Pramstaller PP, Rettig R, Hastie N, Chas-
    man DI, Kao WH, Heid IM, Fox CS (2010)


New loci associated with kidney function and
chronic kidney disease. Nat Genet 42
(5):376–384. https://doi.org/10.1038/ng.


  1. ng.568 [pii]

  2. Yavari A, Stocker CJ, Ghaffari S, Wargent ET,
    Steeples V, Czibik G, Pinter K, Bellahcene M,
    Woods A, Martinez de Morentin PB,
    Cansell C, Lam BY, Chuster A, Petkevicius K,
    Nguyen-Tu MS, Martinez-Sanchez A, Pullen
    TJ, Oliver PL, Stockenhuber A, Nguyen C,
    Lazdam M, O’Dowd JF, Harikumar P,
    Toth M, Beall C, Kyriakou T, Parnis J,
    Sarma D, Katritsis G, Wortmann DD, Harper
    AR, Brown LA, Willows R, Gandra S,
    Poncio V, de Oliveira Figueiredo MJ, Qi NR,
    Peirson SN, McCrimmon RJ, Gereben B,
    Tretter L, Fekete C, Redwood C, Yeo GS,
    Heisler LK, Rutter GA, Smith MA, Withers
    DJ, Carling D, Sternick EB, Arch JR,
    Cawthorne MA, Watkins H, Ashrafian H
    (2016) Chronic activation of gamma2 AMPK
    induces obesity and reduces beta cell function.
    Cell Metab 23(5):821–836.https://doi.org/
    10.1016/j.cmet.2016.04.003

  3. Yavari A, Ashrafian H (2010) Inherited cardiac
    disease. Medicine 38(9):496–501

  4. Cooper LT, Baughman KL, Feldman AM,
    Frustaci A, Jessup M, Kuhl U, Levine GN,
    Narula J, Starling RC, Towbin J, Virmani R
    (2007) The role of endomyocardial biopsy in
    the management of cardiovascular disease: a
    scientific statement from the American Heart
    Association, the American College of Cardiol-
    ogy, and the European Society of Cardiology
    Endorsed by the Heart Failure Society of
    America and the Heart Failure Association of
    the European Society of Cardiology. Eur Heart
    J 28(24):3076–3093. https://doi.org/10.
    1093/eurheartj/ehm456

  5. Fabris E, Brun F, Porto AG, Losurdo P, Vitali
    Serdoz L, Zecchin M, Severini GM,
    Mestroni L, Di Chiara A, Sinagra G (2013)
    Cardiac hypertrophy, accessory pathway, and
    conduction system disease in an adolescent:
    the PRKAG2 cardiac syndrome. J Am Coll
    Cardiol 62(9):e17. https://doi.org/10.
    1016/j.jacc.2013.02.099

  6. Zhang BL, RL X, Zhang J, Zhao XX, Wu H,
    Ma LP, JQ H, Zhang JL, Ye Z, Zheng X, Qin
    YW (2013) Identification and functional analy-
    sis of a novel PRKAG2 mutation responsible
    for Chinese PRKAG2 cardiac syndrome reveal
    an important role of non-CBS domains in reg-
    ulating the AMPK pathway. J Cardiol 62
    (4):241–248.https://doi.org/10.1016/j.jjcc.
    2013.04.010

  7. Arad M, Penas-Lado M, Monserrat L, Maron
    BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson


618 Arash Yavari et al.

Free download pdf